SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549

                                    FORM 10-Q


                 QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934




For Quarter Ended              May 3, 1997
Commission File Number         1-10512


                          DEL GLOBAL TECHNOLOGIES CORP.
                          -----------------------------
             (Exact name of registrant as specified in its charter)


           New York                                 13-1784308
           --------                                 ----------
(State or other jurisdiction of                  (I.R.S. Employer
incorporation or organization)                   Identification No.)

                      One Commerce Park, Valhalla, NY 10595
                      -------------------------------------
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (914) 686-3600
                                 --------------
               (Registrant's telephone number including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

Yes   X                No

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the close of the period covered by this report.

                            Common Stock - 7,393,569




<PAGE>





                                     PART I


Item 1. - FINANCIAL STATEMENTS

              Consolidated Balance Sheets - May 3, 1997 and August 3, 1996

              Consolidated  Statements  of Income for the Three  Months and Nine
              Months ended May 3, 1997 and April 27, 1996

              Consolidated Statements of Cash Flow for the Nine Months ended May
              3, 1997 and April 27, 1996

              Notes to Consolidated Financial Statements

                                       -1-

<PAGE>



                  DEL GLOBAL TECHNOLOGIES CORP. & SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
                                   (Unaudited)

                                     ASSETS
                                                          May 3,      August  3,
                                                           1997         1996
                                                       -----------   -----------

CURRENT ASSETS
    Cash and cash equivalents                          $ 5,757,769   $ 5,817,800
    Investments available-for-sale                         716,015       545,651
    Trade receivables                                    9,856,026     9,221,328
    Cost and estimated earnings in excess of
      billings on uncompleted contracts                  1,301,173          --
    Inventory                                           25,084,130    23,819,882
    Prepaid expenses and other current assets            2,161,281     1,675,039
                                                       -----------   -----------
            Total current assets                        44,876,394    41,079,700
                                                       -----------   -----------

FIXED ASSETS - Net                                      10,576,600     9,538,489
INTANGIBLES - Net                                        1,263,631     1,322,552
GOODWILL - Net                                           4,183,254     4,311,472
DEFERRED CHARGES                                           674,457       784,751
OTHER ASSETS                                               599,765       692,788
                                                       -----------   -----------
        TOTAL                                          $62,174,101   $57,729,752
                                                       ===========   ===========

LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES
        Current portion of long-term debt              $   113,472   $   120,078
        Accounts payable - trade                         4,664,404     3,693,580
        Accrued liabilities                              3,919,764     4,070,202
        Income taxes                                       605,128       643,545
                                                       -----------   -----------
                Total current liabilities                9,302,768     8,527,405
                                                       -----------   -----------

LONG-TERM LIABILITIES
        Long-term debt (less current
           portion included above)                         467,531       499,852
        Other                                              798,861       789,589
        Deferred income taxes                              843,378       843,378
                                                       -----------   -----------
                Total liabilities                       11,412,538    10,660,224
                                                       -----------   -----------

SHAREHOLDERS' EQUITY
        Common stock, $.10 par value;
          Authorized - 20,000,000 shares;
          Issued  and  outstanding -
          7,471,824 shares at May 3, 1997 and
          7,440,108 shares at August 3, 1996               747,182       722,340
        Additional paid-in capital                      45,477,269    43,272,713
        Retained earnings                                5,052,747     3,411,160
                                                       -----------   -----------
                                                        51,277,198    47,406,213
                                                       -----------   -----------
        Less common stock in treasury -
          78,255 shares at May 3, 1997 and
          58,255 shares at August 3, 1996                  515,635       336,685
                                                       -----------   -----------
          Total shareholders' equity                    50,761,563    47,069,528
                                                       -----------   -----------
        TOTAL                                          $62,174,101   $57,729,752
                                                       ===========   ===========

See notes to consolidated financial statements

                                       -2-

<PAGE>



                  DEL GLOBAL TECHNOLOGIES CORP. & SUBSIDIARIES

                        CONSOLIDATED STATEMENTS OF INCOME
                                   (Unaudited)
<TABLE>
<CAPTION>

                                                Three Months Ended              Nine Months Ended
                                          ----------------------------   ----------------------------
                                             May 3,         April 27,       May 3,         April 27,
                                              1997            1996           1997            1996
                                          ------------    ------------   ------------    ------------        
<S>                                       <C>             <C>            <C>             <C>         
NET SALES                                 $ 14,317,165    $ 12,555,138   $ 39,320,420    $ 29,355,757
---------                                 ------------    ------------   ------------    ------------

COSTS AND EXPENSES:
     Cost of sales                           8,944,620       7,973,306     24,009,457      17,717,858
     Research and development                1,190,800         869,886      3,383,239       2,301,780
     Selling, general & administrative       2,365,075       2,232,346      7,124,822       5,588,463
     Interest (income) or expense - net        (30,355)        353,298        (77,651)        948,509
                                          ------------    ------------   ------------    ------------
                                            12,470,140      11,428,836     34,439,867      26,556,610
                                          ------------    ------------   ------------    ------------
INCOME BEFORE PROVISION
   FOR INCOME TAXES                          1,847,025       1,126,302      4,880,553       2,799,147

PROVISION FOR INCOME TAXES                     563,343         343,482      1,488,569         853,700
                                          ------------    ------------   ------------    ------------
NET INCOME                                $  1,283,682    $    782,820   $  3,391,984    $  1,945,447
                                          ============    ============   ============    ============
Per share amounts:
     Net income per common share
     and common share equivalents         $        .15    $        .14   $        .40    $        .34
                                          ============    ============   ============    ============
Weighted average number of                
      common shares outstanding
      and common share equivalents           8,467,700       5,781,557      8,507,759       5,721,441
                                          ============    ============   ============    ============     
</TABLE>



See notes to consolidated financial statements

                                       -3-

<PAGE>



                  DEL GLOBAL TECHNOLOGIES CORP. & SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOW

                                   (Unaudited)

                                                          Nine Months Ended
                                                     ---------------------------
                                                        May 3,        April 27,
                                                         1997           1996
                                                     -----------    ------------
CASH FLOWS FROM OPERATING ACTIVITIES:
   Net Income                                        $ 3,391,984    $ 1,945,447
   Adjustments to reconcile net
     income to net cash provided
     by operating activities:
     Imputed Interest                                     51,045         49,852
     Depreciation                                        722,227        539,637
     Amortization                                        390,621        307,647
     Deferred income tax provision                       195,337         72,657
   Changes in assets and liabilities:
     Increase in trade receivables                      (634,698)    (2,641,087)
     Increase in cost and estimated
       earnings in excess of billings
       on uncompleted contracts                       (1,301,173)        (8,183)
     Increase in inventory                            (1,264,248)      (846,861)
     Increase in prepaid and other current assets       (383,702)      (771,883)
     (Increase) decrease in other assets                  (6,124)        54,142
     Increase in accounts payable - trade                970,824      1,147,253
     (Decrease) increase in accrued liabilities         (423,312)       863,578
     Increase in income taxes payable                    239,538        371,809
                                                     -----------    -----------
        Net cash provided by operating activities      1,948,319      1,084,008
                                                     -----------    -----------

CASH FLOWS FROM INVESTING ACTIVITIES:
   Expenditures for fixed assets                      (1,760,338)    (1,082,601)
   Net cash paid on acquisition of subsidiaries          (15,000)    (5,815,540)
   Investment in marketable securities - net            (170,364)      (142,644)
   Payments to former shareholders of
     subsidiary acquired                                 (41,775)       (39,422)
                                                     -----------    ----------- 
        Net cash used in investing activities         (1,987,477)    (7,080,207)
                                                     -----------    ----------- 

CASH FLOWS FROM FINANCING ACTIVITIES:
   Net (repayment of) proceeds from bank borrowing       (38,927)     4,803,572
   Payment for repurchase of shares                     (178,950)       (19,770)
   Proceeds from exercise of stock options
      and warrants                                       175,338      1,059,099
   Other                                                  21,666        (95,079)
                                                     -----------    ----------- 
        Net cash (used in) provided by financing     
           activities                                    (20,873)     5,747,822
                                                     -----------    -----------

                                                                     (Continued)
See notes to consolidated financial statements






                                       -4-

<PAGE>




                  DEL GLOBAL TECHNOLOGIES CORP. & SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOW

                                   (Unaudited)


                                                          Nine Months Ended
                                                     ---------------------------
                                                        May 3,        April 27,
                                                         1997           1996
                                                     ------------   ------------

NET DECREASE IN CASH AND CASH EQUIVALENTS            $   (60,031)   $  (248,377)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD         5,817,800        505,989
                                                     -----------    -----------
CASH AND CASH EQUIVALENTS, END OF PERIOD             $ 5,757,769    $   257,612
                                                     ===========    ===========
                                                     

SUPPLEMENTAL DISCLOSURES OF CASH FLOW
   INFORMATION:
     Interest paid                                   $    36,109    $   662,421
                                                     ===========    ===========
     Income taxes paid                               $ 1,091,188    $   434,405
                                                     ===========    ===========

SUPPLEMENTAL SCHEDULE OF INVESTING AND
   FINANCING ACTIVITIES:
   Acquisition of subsidiary                         $    15,000    $ 7,707,915
                                                     -----------    -----------
   Subordinated note payable for acquisition                          1,800,000
   Acquisition costs in accrued expenses                                 92,375
                                                                    -----------
                                                                      1,892,375
                                                                    -----------
   Cash paid to acquire subsidiary                   $    15,000    $ 5,815,540
                                                     ===========    ===========

Tax benefit related to exercise of stock
   options and warrants                              $   277,955    $   139,397
                                                     ===========    ===========




                                                                     (Concluded)

See notes to consolidated financial statements

                                       -5-

<PAGE>



                  DEL GLOBAL TECHNOLOGIES CORP. & SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

                                   (Unaudited)

NOTE 1         In the  opinion of the  Company's  management,  the  accompanying
               unaudited   consolidated   financial   statements   contain   all
               adjustments  (consisting  of only normal  recurring  adjustments)
               necessary  to  present   fairly  the  results  of  the  Company's
               financial  position  as of May 3,  1997  and the  results  of its
               operations  and its cash flows for the nine  months  ended May 3,
               1997 and April 27, 1996.

               The accounting  policies followed by the Company are set forth in
               Note 1 to the  Company's  financial  statements  as of  August 3,
               1996.

               The  consolidated   financial   statements   should  be  read  in
               conjunction  with the  notes to the  financial  statements  as of
               August 3, 1996.

NOTE 2         The results of operations  for the nine month period ended May 3,
               1997 are not necessarily indicative of the results to be expected
               for the full year.

NOTE 3         PERCENTAGE OF COMPLETION ACCOUNTING

                                                                      Balance at
                                                                     May 3, 1997
                                                                     -----------

               Costs incurred on uncompleted contracts                $1,482,248

               Estimated earnings                                        667,050
                                                                      ----------
                                                                       2,149,298

               Less:  Billings to-date                                   848,125
                                                                      ----------
               Costs and estimated earnings in excess
                  of billings on uncompleted contracts                $1,301,173
                                                                      ==========

               The backlog of unshipped  contracts being accounted for under the
               percentage of completion  method of accounting  was $4,279,640 at
               May 3, 1997.

NOTE 4         INVENTORY

               Inventory is stated at a lower of cost  (first-in,  first-out) or
               market.

               Inventories  and their effect on cost of sales are  determined by
               physical count for annual reporting purposes and are estimated by
               management for interim reporting purposes.

                 Inventory consists of the following: 
                                                       May 3, 1997  Aug. 3, 1996
                                                       -----------  ------------
                                                       
                 Finished goods                        $ 5,769,350   $ 5,463,847
                 Work-in-process                        10,033,652     9,538,081
                 Raw material and purchased parts        9,281,128     8,817,954
                                                       -----------   -----------
                 Total                                 $25,084,130   $23,819,882
                                                       ===========   ===========

                                       -6-

<PAGE>




NOTE 5           FIXED ASSETS

                 Fixed assets consist of the following:
                                                 May 3, 1997        Aug. 3, 1996
                                                 -----------        ------------

                 Land                            $   694,046         $   694,046
                 Building                          2,146,025           2,146,025
                 Machinery and equipment           9,653,761           8,426,324
                 Furniture and fixtures            1,268,173             833,880
                 Leasehold improvements            1,156,676           1,043,996
                 Construction in progress            397,352             435,102
                 Transportation equipment             30,103              11,425
                                                 -----------         -----------
                                                  15,346,136          13,590,798
                 Less accumulated depreciation
                    and amortization               4,769,536           4,052,309
                                                 -----------         -----------
                 Net fixed assets                $10,576,600         $ 9,538,489
                                                 ===========         ===========

NOTE 6         Net income per common share was computed using the treasury stock
               method.  The weighted  average number of common shares and common
               share  equivalents  for the period and for all periods  presented
               includes the effect of the 3 percent stock  dividend (see Note 7)
               declared on November 19, 1996.
 
NOTE 7         On November  19,  1996,  the Company  declared a 3 percent  stock
               dividend  to  holders  of record on  December  4,  1996,  payable
               December 23, 1996.

NOTE 8         ACQUISITION

               As of March  6,  1996,  the  Company's  wholly-owned  subsidiary,
               Gendex-Del  Medical  Imaging  Corp.,  acquired  certain  selected
               assets of the Gendex Medical  Division of Dentsply  International
               Inc.

               Unaudited pro-forma  financial  information for the 3 and 9 month
               periods  ended  April  27,  1996,   as  if  the  Gendex   Medical
               acquisition  occurred at the beginning of the respective periods,
               is as follows:
                                                      Three Months   Nine Months
                                                          Ended         Ended 
                                                        April 27,     April 27,
                                                           1996          1996 
                                                       -----------   -----------
                                                            
               Net Sales                               $14,125,572   $39,778,604
                                                       ===========   ===========

                Income before provision
                for income taxes                       $ 1,046,963   $ 2,302,594
                                                       ===========   ===========

                Net Income                             $   727,639   $ 1,600,303
                                                       ===========   ===========

                Net income per common share
                and common share equivalents
                primary and fully diluted              $       .13   $       .29
                                                       ===========   ===========

               The  pro  forma  financial  information  presented  above  is not
               necessarily  indicative of the operating results which would have
               been  achieved  had the Company  acquired  Gendex  Medical at the
               beginning  of  the  periods  presented  or of the  results  to be
               achieved in the future.

                                       -7-

<PAGE>



Item 2. - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS

RESULTS OF OPERATIONS

        Net  sales  for the three  months  ended May 3, 1997 were  approximately
$14.3 million compared to approximately $12.6 million for the three months ended
April 27, 1996, an increase of 14.0 percent over the corresponding period in the
prior year.  Net sales for the nine months ended May 3, 1997 were  approximately
$39.3  million as compared to  approximately  $29.4  million for the nine months
ended April 27, 1996,  an increase of 33.9 percent.  These  increases are due to
the inclusion of net sales from the Gendex-Del subsidiary and internal growth.

        Cost of sales,  as a percentage  of net sales for the three months ended
May 3, 1997,  was 62.5  percent  compared to 63.5  percent for the three  months
ended April 27, 1996. Cost of sales, as a percentage of net sales,  for the nine
months  ended May 3, 1997 was 61.1  percent as compared to 60.4  percent for the
nine months ended April 27,  1996.  This change was due to the change in product
mix in the  periods.  The current  year  period  includes  the gross  margins of
medical imaging systems manufactured by Gendex-Del.

        Research  and  development  expenses  increased  to  approximately  $1.2
million for the three months ended May 3, 1997 from  approximately  $870,000 for
the three  months  ended  April 27,  1996.  Research  and  development  expenses
increased  to  approximately  $3.4 million for the nine months ended May 3, 1997
from  approximately  $2.3 million for the nine months ended April 27, 1996.  The
increase was  attributable  to Gendex-Del  and  increases in other  research and
development  activities.  The  Company  continues  to  invest  in  research  and
development in order to introduce new state-of-the-art  products for its medical
and industrial markets.

        Selling,  general and  administrative  expenses were  approximately $2.4
million for the three months ended May 3, 1997 as compared to approximately $2.2
million  for  the  same  period  in  the  prior  year.   Selling,   general  and
administrative  expenses  increased to  approximately  $7.1 million for the nine
months ended May 3, 1997 from  approximately $5.6 million for the same period in
the prior year.  These increases are primarily  attributable to the inclusion of
the selling, general and administrative expenses of Gendex-Del.

        Net interest income was approximately $30,000 for the three months ended
May 3, 1997 as compared to net interest  expense of  approximately  $353,000 for
the   corresponding   period  in  the  prior  year.  Net  interest   income  was
approximately  $78,000  for the nine  months  ended May 3, 1997 as  compared  to
approximately  $949,000 of interest expense for the corresponding  prior period.
Interest expense was significantly reduced as the Company paid off substantially
all of its debt.  Interest  income  resulted from the  investment of some of the
proceeds from the public  offering of the Company's  common stock,  which are in
money market instruments and high grade commercial paper.

        Income tax  expense  was 30.5  percent  of  pre-tax  income for the nine
months  ended May 3, 1997 and for the nine  months  ended  April 27,  1996.  The
decrease from  statutory  rates is primarily due to sales being made through the
Company's  Foreign Sales  Corporation,  research and  development  and other tax
credits.

                                       -8-

<PAGE>



        Net income increased to approximately  $1.3 million for the three months
ended May 3, 1997, an increase of 64.0 percent from  approximately  $783,000 for
the prior corresponding period. Net income per common share for the three months
ended May 3, 1997  increased  to $.15 from $.14,  on a primary and full  diluted
basis,  even though the weighted number of common shares  outstanding and common
share  equivalents  increased 46.5 percent to 8,467,700 from 5,781,557 shares in
the prior  corresponding  period.  Net income  increased to  approximately  $3.4
million for the nine months ended May 3, 1997,  an increase of 74.4 percent from
approximately  $1.9 million for the prior  corresponding  period. Net income per
common share for the nine months ended May 3, 1997  increased to $.40 from $.34,
on a primary and fully diluted basis,  even though the weighted number of common
shares  outstanding  and common  share  equivalents  increased  48.7  percent to
8,507,759 from 5,721,441 shares in the prior corresponding period. The increases
in net  income  for the  three  and nine  month  periods  ended  May 3, 1997 are
primarily due to higher sales to the Company's  medical  imaging and  diagnostic
product customers and the reduction of interest expense.

        The  Company's  growth  strategy  continues to be to grow  internally by
expanded  product  development  and  marketing and by  acquisition  and/or joint
ventures with specific focus on  cost-effective  medical  imaging and diagnostic
products.

        The backlog of unshipped orders at May 3, 1997 was  approximately  $22.1
million.

LIQUIDITY AND CAPITAL RESOURCES

        The  Company  has  funded  its  operations  and  acquisitions  through a
combination of cash flow from operations, bank borrowing and the issuance of the
Company's common stock.

        Working  Capital.  At May 3, 1997 and  August  3,  1996,  the  Company's
working capital was approximately $35.6 million and $32.6 million, respectively.
On May 3, 1997 and August 3, 1996 the Company had approximately  $5.8 million in
cash and cash equivalents.

        Inventory  at  May 3,  1997  increased  approximately  $1.3  million  as
compared to August 3, 1996.  Major new orders  received in the quarter ended May
3, 1997 resulted in the increase of inventory levels.

        Credit  Facility and Borrowing.  At May 3, 1997, the Company had a $14.0
million revolving credit line and a $10.0 million  acquisition  credit line. The
available portion of the revolving credit line was approximately  $13.7 million,
after deducting  outstanding  letters of credit of approximately  $169,000,  and
approximately $9.6 million was available under its acquisition credit line.


        Capital  Expenditures.  The  Company  continues  to  invest  in  capital
equipment, principally for its manufacturing operations, in order to improve its
manufacturing  capability and capacity.  The Company has expended  approximately
$623,000  and $1.8  million for capital  equipment  for the three month and nine
month periods ended May 3, 1997, respectively.

        The Company  anticipates that cash generated from operations and amounts
available  under its bank lending  facilities  will be sufficient to satisfy its
current operating cash needs.

                                       -9-

<PAGE>



Item 3. - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

             None.









































                                      -10-

<PAGE>



                                     PART II

Item 1.        Legal Proceedings

                      None

Item 2.        Changes in Securities

                      None

Item 3.        Defaults Upon Senior Securities

                      None

Item 4.        Submission of Matters to a Vote of Security Holders

                      None

Item 5.        Other Information

                      None

Item 6.        Exhibits and Reports on Form 8-K

               (a)    Exhibits:
                               Exhibit 11  - Computation of Earnings per Common
                                                Share
                               Exhibit 27  - Financial Data Schedule

               (b)   Report on Form 8-K - None






                                      -11-

<PAGE>



                                   SIGNATURES


               Pursuant to the  requirements  of the Securities and Exchange Act
of 1934,  the  Registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.










                                               DEL GLOBAL TECHNOLOGIES CORP.




                                               /S/LEONARD A. TRUGMAN
                                               ---------------------
                                               Leonard A. Trugman
                                               Chairman of the Board,
                                               Chief Executive Officer
                                               and President




                                               /S/MICHAEL H. TABER
                                               ---------------------
                                               Michael H. Taber
                                               Vice President - Finance,
                                               Secretary and Chief
                                               Accounting Officer



Dated:  June 13, 1997